The tool uses amyloid PET scans and genetic information and predicts both the lifetime and 10-year risks of developing mild cognitive impairment (MCI) and dementia. Not only does the tool predict risk, but it can also predict it before symptoms مزید پڑھیں
TSPO levels rise early in Alzheimer’s and persist throughout disease. Targeting this biomarker could open new treatment options. TSPO, a major marker of brain inflammation, may offer a way to detect Alzheimer’s disease long before memory problems and other symptoms مزید پڑھیں